Literature DB >> 7018430

Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli.

L B Hinshaw, B K Beller-Todd, L T Archer, B Benjamin, D J Flournoy, R Passey, M F Wilson.   

Abstract

Early aggressive therapy with maintenance infusions of methylprednisolone sodium succinate and gentamicin sulfate significantly increases the probability for survival of baboons given LD100 Escherichia coli. The present study was designed to determine if baboons would recover when initiation of treatment was delayed until they had sustained E. coli-induced systemic hypotension for a period of approximately three hours. Sixteen adult baboons were each administered a two-hour infusion of LD100 E. coli. All eight untreated animals died within 42 hours. Five of the eight baboons treated after approximately three hours of hypotension with methylprednisolone sodium succinate and gentamicin sulfate survived. Treated animals had significantly higher blood glucose and insulin levels and lower blood urea nitrogen concentrations than baboons receiving E. coli alone. E. coli blood concentrations were lower in the treated than in the untreated baboon group by the sixth hour (less than 0.02). Heart rates increased in all animals but were not as high in the treated baboons. Both groups experienced similar decreases in mean systemic arterial pressure, PCO2, base excess, leukocyte, lymphocyte, and platelet concentrations, and increases in creatinine and lactate concentrations. Data from the present study indicate that the probability of recovery from shock is significantly increased even when initiation of steroid/antibiotic therapy is postponed until baboons have experienced sustained systemic hypotension.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7018430      PMCID: PMC1345194          DOI: 10.1097/00000658-198107000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  10 in total

1.  A pathologic study of Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment.

Authors:  J J Coalson; B A Benjamin; L T Archer; B K Beller; R H Spaet; L B Hinshaw
Journal:  Surg Gynecol Obstet       Date:  1978-11

2.  Recovery from lethal Escherichia coli shock in dogs.

Authors:  L B Hinshaw; B K Beller; L T Archer; D J Flournoy; G L White; R W Phillips
Journal:  Surg Gynecol Obstet       Date:  1979-10

3.  Blood insulin responses to blood glucose levels in high output sepsis and spetic shock.

Authors:  G H Clowes; H Martin; S Walji; E Hirsch; R Gazitua; R Goodfellow
Journal:  Am J Surg       Date:  1978-04       Impact factor: 2.565

4.  Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage.

Authors:  G H Clowes; T F O'Donnell; N T Ryan; G L Blackburn
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

5.  Endotoxin shock. Hemodynamic and survival effects of methylprednisolone.

Authors:  L B Hinshaw; L A Solomon; P C Freeny; D A Reins
Journal:  Arch Surg       Date:  1967-01

6.  Survival of primates in LD100 septic shock following steroid/antibiotic therapy.

Authors:  L B Hinshaw; L T Archer; B K Beller-Todd; J J Coalson; D J Flournoy; R Passey; B Benjamin; G L White
Journal:  J Surg Res       Date:  1980-02       Impact factor: 2.192

7.  The hepatic failure of sepsis: cellular versus substrate.

Authors:  F B Cerra; J H Siegel; J R Border; J Wiles; R R McMenamy
Journal:  Surgery       Date:  1979-09       Impact factor: 3.982

8.  Mechanism of decreased venous return. Subhuman primate-administered endotoxin.

Authors:  L B Hinshaw; L L Shanbour; L J Greenfield; J J Coalson
Journal:  Arch Surg       Date:  1970-05

9.  Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment.

Authors:  L B Hinshaw; J J Coalson; B A Benjamin; L T Archer; B K Beller; O R Kling; E M Hasser; R W Phillips
Journal:  Surg Gynecol Obstet       Date:  1978-10

10.  Steroids in the treatment of clinical septic shock.

Authors:  W Schumer
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

  10 in total
  11 in total

1.  Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli.

Authors:  L Molina; S Studenberg; G Wolberg; W Kazmierski; J Wilson; A Tadepalli; A C Chang; S Kosanke; L Hinshaw
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

2.  Activation of plasma systems and blood cells by endotoxin in rabbits.

Authors:  N J Jansen; W van Oeveren; B H Hoiting; C R Wildevuur
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

3.  Treatment of bacteremia.

Authors:  J N Sheagren
Journal:  West J Med       Date:  1986-02

Review 4.  The case for steroids: another viewpoint.

Authors:  W J Sibbald
Journal:  Intensive Care Med       Date:  1984       Impact factor: 17.440

Review 5.  Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.

Authors:  P Minneci; K Deans; C Natanson; P Q Eichacker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-01-28       Impact factor: 3.267

6.  Lipid X ameliorates pulmonary hypertension and protects sheep from death due to endotoxin.

Authors:  D T Golenbock; J A Will; C R Raetz; R A Proctor
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

7.  Lipid X protects mice against fatal Escherichia coli infection.

Authors:  D T Golenbock; J E Leggett; P Rasmussen; W A Craig; C R Raetz; R A Proctor
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

8.  Effect of methylprednisolone on bacterial clearance and endotoxin liberation during experimental sepsis induced by gram-negative bacteria.

Authors:  P M Flynn; J L Shenep; D C Stokes; W K Hildner; P W Mackert; R L Snellgrove; J E Rehg
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

Review 9.  Strategies to improve drug development for sepsis.

Authors:  Mitchell P Fink; H Shaw Warren
Journal:  Nat Rev Drug Discov       Date:  2014-09-05       Impact factor: 84.694

Review 10.  Animal models of sepsis.

Authors:  Mitchell P Fink
Journal:  Virulence       Date:  2013-08-19       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.